Senseonics Holdings, Inc. (NYSE:SENS) Receives $1.54 Consensus Price Target from Analysts

Key Points

• Senseonics Holdings, Inc. has received a consensus "Buy" recommendation from five research firms, with three firms rating it as "buy" and two as "strong buy".
• The average 12-month price target set by analysts for Senseonics is $1.5375, with recent price objectives from firms ranging from $1.25 to $1.50.
• Only 12.36% of Senseonics' stock is owned by institutional investors and hedge funds, indicating potential for increased investment interest.

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given a consensus recommendation of "Buy" by the five ratings firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $1.5375.

SENS has been the subject of a number of research reports. HC Wainwright reaffirmed a "buy" rating and set a $1.40 target price (up previously from $1.10) on shares of Senseonics in a report on Tuesday, July 8th. Barclays began coverage on shares of Senseonics in a research report on Wednesday, August 27th. They set an "overweight" rating and a $1.50 price target on the stock. Lake Street Capital raised shares of Senseonics to a "strong-buy" rating in a research report on Thursday, July 17th. Finally, TD Cowen began coverage on shares of Senseonics in a research report on Tuesday, July 15th. They set a "buy" rating and a $1.25 price target on the stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of SENS. First Light Asset Management LLC lifted its position in Senseonics by 666.7% in the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company's stock valued at $17,011,000 after buying an additional 31,050,619 shares during the last quarter. Hood River Capital Management LLC acquired a new position in Senseonics in the second quarter valued at about $3,775,000. Sio Capital Management LLC acquired a new position in Senseonics in the second quarter valued at about $2,312,000. Geode Capital Management LLC lifted its position in Senseonics by 26.6% in the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company's stock valued at $4,147,000 after buying an additional 1,828,302 shares during the last quarter. Finally, Sei Investments Co. acquired a new position in Senseonics in the second quarter valued at about $761,000. Institutional investors and hedge funds own 12.36% of the company's stock.

Senseonics Price Performance

Shares of Senseonics stock traded up $0.00 during trading hours on Friday, reaching $0.46. 7,361,587 shares of the company's stock were exchanged, compared to its average volume of 7,899,737. Senseonics has a 1 year low of $0.25 and a 1 year high of $1.40. The company has a market capitalization of $376.38 million, a P/E ratio of -3.55 and a beta of 0.93. The business has a fifty day moving average of $0.48 and a two-hundred day moving average of $0.55. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.